Edwards Lifesciences Trade and Non Trade Receivables Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 117.45  0.58  0.49%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Trade and Non Trade Receivables of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing trade and non-trade receivables.
Trade and Non Trade Receivables  10 Years Trend  
Increasing
Slightly volatile
 Trade and Non Trade Receivables 
      Timeline 

Edwards Lifesciences Trade and Non Trade Receivables Over Time

2015-12-31  371,800,000 
2016-12-31  414,600,000 
2017-12-31  413,894,737 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  299,524,561
Geometric Mean  278,217,543
Coefficient Of Variation  33.74
Mean Deviation  79,233,041
Median  335,300,000
Standard Deviation  101,066,350
Range  314,000,000
R Value  0.93
R Squared  0.86
Significance  0.00001304
Slope  26,026,721

Currently Trending

VMW   
 NYQ 
Purchased over 20 shares of
2 days ago ago
Traded for 114.54
S   
 NYQ 
Purchased over 500 shares of
2 days ago ago
Traded for 5.74
MSFT   
 NMS 
Purchased over 30 shares of
2 days ago ago
Traded for 81.59